Mechanism of Inhibition of Cyclic Nucleotide–Gated Channel by Protein Tyrosine Kinase Probed with Genistein by Molokanova, Elena & Kramer, Richard H.
 
219
 
J. Gen. Physiol.
 
 © The Rockefeller University Press 
 
•
 
 0022-1295/2001/03/219/15 $5.00
Volume 117 March 2001 219–233
http://www.jgp.org/cgi/content/full/117/3/219
 
Mechanism of Inhibition of Cyclic Nucleotide–gated Channel by Protein 
Tyrosine Kinase Probed with Genistein
 
Elena Molokanova 
 
and
 
 Richard H. Kramer
 
From the Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California
 
abstract
 
Rod cyclic nucleotide–gated (CNG) channels are modulated by changes in tyrosine phosphorylation
catalyzed by protein tyrosine kinases (PTKs) and phosphatases (PTPs). We used genistein, a PTK inhibitor, to
probe the interaction between the channel and PTKs. Previously, we found that in addition to inhibiting tyrosine
 
phosphorylation of the rod CNG channel 
 
a
 
-subunit (RET
 
a
 
), genistein triggers a noncatalytic inhibitory interac-
tion between the PTK and the channel. These studies suggest that PTKs affects RET
 
a
 
 channels in two ways: (1) by
catalyzing phosphorylation of the channel protein, and (2) by allosterically regulating channel activation. Here,
we study the mechanism of noncatalytic inhibition. We ﬁnd that noncatalytic inhibition follows the same activity
dependence pattern as catalytic modulation (phosphorylation): the efﬁcacy and apparent afﬁnity of genistein in-
hibition are much higher for closed than for fully activated channels. Association rates with the genistein–PTK
complex were similar for closed and fully activated channels and independent of genistein concentration. Dissoci-
ation rates were 100 times slower for closed channels, which is consistent with a much higher afﬁnity for
genistein–PTK. Genistein–PTK affects channel gating, but not single channel conductance or the number of ac-
tive channels. By analyzing single channel gating during genistein–PTK dissociation, we determined the maximal
open probability for normal and genistein–PTK-bound channels. genistein–PTK decreases open probability by in-
 
creasing the free energy required for opening, making opening dramatically less favorable. Ni
 
2
 
1
 
, which potenti-
ates RET
 
a
 
 channel gating, partially relieves genistein inhibition, possibly by disrupting the association between
the genistein–PTK and the channel. Studies on chimeric channels containing portions of RET
 
a
 
, which exhibits
genistein inhibition, and the rat olfactory CNG channel 
 
a
 
-subunit, which does not, reveals that a domain contain-
ing S6 and ﬂanking regions is the crucial for genistein inhibition and may constitute the genistein–PTK binding
site. Thus, genistein–PTK stabilizes the closed state of the channel by interacting with portions of the channel that
participate in gating.
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INTRODUCTION
 
Cyclic nucleotide–gated (CNG)
 
1
 
 channels are crucial
for generating electrical signals during phototransduc-
tion in vertebrate photoreceptors. Light triggers a de-
crease in the cytoplasmic concentration of cGMP, caus-
ing CNG channels in the plasma membrane to close.
CNG channels are not invariant reporters of the
changes in cGMP concentration, but rather the sensi-
 
tivity of CNG channels to cGMP can be modulated
by intracellular and extracellular signals. Intracellular
 
Ca
 
2
 
1
 
 causes a decrease in cGMP sensitivity of rod CNG
channels, mediated by direct binding of calmodulin
and other Ca
 
2
 
1
 
-binding proteins to the CNG channel
(Hsu and Molday, 1993; Chen et al., 1994; Gordon et
al., 1995a). Rod CNG channels are modulated by tran-
sition metals (Zn
 
2
 
1
 
 and Ni
 
2
 
1
 
), which increase cGMP
sensitivity (Ildefonse and Bennett, 1991; Gordon and
Zagotta, 1995a; Karpen et al., 1993) and diacylglycerol
and other phospholipid derivatives, which inhibit the
channels (Gordon et al., 1995b; Womack et al., 2000).
CNG channels can be modulated by changes in the
phosphorylation state catalyzed by Ser/Thr kinases
(Muller et al., 1998) and phosphatases (Gordon et al.,
1992). We have recently shown that the sensitivity of
 
rod CNG channels can be modulated by tyrosine
dephosphorylation by protein tyrosine phosphatases
(PTPs) and phosphorylation by protein tyrosine ki-
nases (PTKs; Molokanova et al., 1997). Moreover, the
target of tyrosine phosphorylation is the channel pro-
tein itself, with the crucial phosphorylation site located
 
on the cyclic nucleotide binding site of the 
 
a
 
-subunits
of the rod CNG channel (Molokanova et al., 1999b).
Modulation by tyrosine phosphorylation is dependent
on the activation state of the channel. Thus, dephos-
phorylation, which favors channel opening, requires
open channels, whereas phosphorylation, which pro-
motes channel closing, requires closed channels.
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 CNG, cyclic nucleotide–gated; PTK,
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Remarkably, it appears that PTKs can affect rod CNG
channels not only by catalyzing phosphorylation, but
also through allosteric regulation by a direct protein–
protein interaction. This conclusion came to light
while using genistein, a PTK inhibitor. Genistein com-
petes with ATP binding to PTKs, but does not compete
with protein substrates that bind to PTKs at a distinct
site (Akiyama et al., 1987). We found that genistein not
only prevents PTK from phosphorylating the channel
in the presence of ATP, but also inhibits cGMP-acti-
vated current through CNG channel in the absence of
ATP (Molokanova et al., 1999a). Moreover, structural
and functional studies suggest that CNG channels do
not have ATP binding sites to accommodate genistein.
Therefore, it seemed possible that genistein does not
bind directly, but rather acts indirectly, by binding to an
accessory protein that subsequently binds to the CNG
channel. The effect of genistein is inhibited by other
PTK inhibitors that, by themselves, have no effect on
the rod CNG channels. Thus, AMP-PNP, which com-
petes with genistein for inhibition of PTKs, is a compet-
itive inhibitor of genistein’s action on CNG channels,
whereas erbstatin, a noncompetitive inhibitor of PTKs,
noncompetitively prevents genistein’s effect on the
channels. Taken together, these ﬁndings strongly sug-
gest that genistein inhibition involves a noncatalytic, al-
losteric effect of the PTK on CNG channels.
Activation of CNG channels is a result of conforma-
tional changes in protein structure in response to
ligand binding to the cytoplasmic cyclic nucleotide–
binding domains. How does PTK affect channel activa-
tion? After exposure to genistein, the PTK might specif-
ically reduce agonist binding afﬁnity by altering the
geometry of the cyclic nucleotide binding site. Alter-
nately, the PTK might impose conformational con-
straints on the channel protein, hindering channel gat-
ing. The goal of this study is to distinguish between
these possibilities and clarify the mechanism of gen-
istein–PTK inhibition of rod CNG channels.
 
MATERIALS AND METHODS
 
Expression and Recording of CNG Currents
 
CNG channels were expressed in
 
 Xenopus laevis 
 
oocytes. Oocytes
were injected with 50 nl containing either 1 ng/
 
m
 
l RNA (for sin-
gle-channel experiments) or 50 ng/
 
m
 
l RNA (macroscopic cur-
rents) encoding the 
 
a
 
-subunit of the bovine retinal rod CNG
channel (RET
 
a
 
; Kaupp et al., 1989), 
 
a
 
-subunit of the rat olfac-
tory CNG channel (OLF
 
a
 
; Dhallan et al., 1990), and several chi-
meric channels (Gordon and Zagotta, 1995a,b). After 2–7 d, the
vitelline membrane was removed, and the oocytes were placed in
a chamber for patch-clamp recording with glass patch pipets (3–
4 M
 
V
 
). Inside-out membrane patches usually containing 100–
200 channels were studied in symmetrical control solution con-
taining (in mM): 115 NaCl, 5 EGTA, 1 EDTA, and 5 HEPES, pH
7.5 with NaOH. cGMP and/or genistein were added to the intra-
cellular control solution. EDTA and EGTA were excluded from
Ni
 
2
 
1
 
-containing solutions. After formation of a gigaohm seal, in-
 
side-out patches were excised and the patch pipet was quickly
(
 
,
 
30 s) placed in the outlet of a 1-mm-diam tube for cGMP ap-
plication. We used a perfusion manifold containing up to eight
different solutions that is capable of solution changes within 50
ms. cGMP was obtained from Sigma-Aldrich, and genistein was
obtained from LC Laboratories.
 
Data Acquisition and Analysis
 
Current responses through CNG channels were obtained with a
patch-clamp (model Axopatch 200A; Axon Instruments), digitized,
stored, and later analyzed on a Pentium PC using pClamp 6.0 soft-
ware. Membrane potential was held at 
 
2
 
75 mV. Current responses
were normalized to the maximal CNG current (I
 
max
 
), elicited by
saturating (2 mM) cGMP. Normalized dose–response curves were
ﬁt to the Hill equation: I/I
 
max 
 
5
 
 1/(1 
 
1 
 
(K
 
1/2
 
/A)
 
n
 
), where A is the
cGMP concentration and
 
 
 
n
 
 
 
is the Hill coefﬁcient, using a nonlin-
ear least squares ﬁtting routine (Origin; Microcal Software, Inc.).
To estimate the K
 
i
 
 for genistein, we used a modiﬁed Hill equation:
I
 
b
 
/I
 
max
 
 
 
5
 
 (1
 
2 
 
(I
 
b(max)
 
/I
 
max
 
))/(1 
 
1 
 
(K
 
i
 
/B)
 
n
 
) 
 
1
 
 I
 
b(max)
 
/I
 
max
 
, where B
is the concentration of blocker, and I
 
b
 
 and I
 
b(max)
 
 are the currents
activated by saturating cGMP in the presence of a given blocker
concentration and a saturating blocker concentration, respectively.
Variability is expressed as mean 
 
6 
 
SEM.
 
Single Channels
 
Single CNG channels in membrane patches from mRNA-injected
oocytes incubated at 18
 
8
 
C ﬁrst appeared 12–18 h after mRNA in-
jection. After this low level of expression was reached, the incu-
bation temperature was reduced to 4
 
8
 
C to stop further expres-
sion. Single CNG channel currents were recorded from excised
inside-out membrane patches using borosilicate glass pipets
coated with Sylgard (Sigma-Aldrich) and ﬁre-polished to resis-
tance of 5–10 M
 
V
 
. The experiments were conducted at room
temperature (20–22
 
8
 
C).
Membrane potential was held at 
 
2
 
80 mV. Single channel
events were sampled at 25 kHz and low-pass ﬁltered at 5 kHz
through an eight-pole Bessel ﬁlter. The opening and closing
event was idealized by measuring the amplitude and dwell time,
using the half-amplitude threshold detection technique
(PClamp6; Axon Instruments). All-points amplitude histograms
were constructed from at least 40 s of continuous data recordings
and ﬁt by the sum of two Gaussian functions, representing the
closed and open states, and used to determine the amplitude of
single-channel currents.
 
RESULTS
 
Genistein Inhibition of Closed and Open CNG Channels
 
CNG channels are normally activated within several
milliseconds of application by direct binding of cyclic
nucleotides. In excised patches, the limiting factor in
activation is diffusion of the ligand to the binding sites.
In the presence of genistein, channel activation is
slowed dramatically and the steady-state cGMP-acti-
vated current is reduced.
To examine the interaction between closed channels
and genistein–PTK, various concentration of genistein
were preapplied on patches for 1 min followed by ap-
plication of saturating cGMP (Fig. 1 A). At subsaturat-
ing genistein concentrations, a fraction of the total cur-
rent, which we call “residual current,” activates over the
normal rapid time course. The magnitude of the resid- 
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ual current is inversely proportional to genistein con-
centration, presumably reﬂecting the fraction of chan-
nels devoid of genistein (Molokanova et al., 1999a).
Analyzing the interaction between genistein–PTK
and open channels is more difﬁcult because, even
with saturating cGMP present, the rod CNG channels
ﬂicker between open and closed states. As an alterna-
tive to studying open channels, we studied fully acti-
vated channels, by applying various concentrations of
genistein in the presence of saturating cGMP and re-
cording steady-state currents (Fig. 1 B). For both
closed and fully activated channels, genistein inhibi-
tion was proportional to genistein concentration, and
the steady-state level of inhibition was the same re-
gardless of the order of genistein and cGMP applica-
tion.
 
Amplitudes of the residual currents (effect on closed
channels) and steady-state currents (effect on fully acti-
vated channels) were used to generate dose–inhibition
curves for genistein (Fig. 1 C). Comparison of closed
versus fully activated channels reveals dramatic differ-
ences. First, the efﬁcacy of genistein inhibition was
higher for closed channels, with inhibition being nearly
complete (98 
 
6 
 
3%, 
 
n 
 
5 
 
34) versus incomplete for fully
activated channels (65 
 
6 
 
6%, 
 
n
 
 
 
5
 
 28). Second, genistein
had a much higher apparent afﬁnity for closed chan-
nels, with K
 
i
 
 values of 4.3 
 
6 
 
0.9 
 
m
 
M (
 
n 
 
5
 
 22) for closed
channels and 84.1 
 
6
 
 6.8 
 
m
 
M (
 
n 
 
5
 
 16) for fully activated
channels. Thus, genistein inhibition of cGMP-activated
currents exhibited activity-dependent pattern demon-
strated previously for tyrosine phosphorylation of CNG
channels (Molokanova et al., 1999b): closed channels
Figure 1. Genistein is more potent in inhibiting closed than fully activated RETa channels. (A) Inhibition of closed channels by preex-
posure to various concentrations of genistein for 1 min. Closed channels were activated by application of saturating cGMP. Residual cur-
rents at ﬁve different genistein concentrations are indicated by dotted lines, and the genistein concentrations are indicated by letter to the
right of each trace. In parts A and B the letter refers to the genistein concentration key. (B) Inhibition of steady-state CNG current, fully ac-
tivated by saturating cGMP. The ﬁve different genistein concentrations are indicated by letter to the right of each trace. (C) Dose–inhibi-
tion curves of the effect of genistein on closed (residual current as in part A; n 5 36) and fully activated channels (steady-state current, as
in part B; n 5 28). Continuous curves show ﬁts of the data to the Hill equation. (D) Apparent afﬁnity (Ki) and Hill coefﬁcients derived
from the Hill equation ﬁts to dose–inhibition curves for closed and fully activated CNG channels ([open circles] closed channels; [ﬁlled
circles] fully activated channels, as in Fig. 1 C). 
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are much more susceptible to both catalytic and noncat-
alytic actions of PTK than are fully activated channels.
We also observed a difference in the Hill coefﬁcient
of genistein inhibition of closed and fully activated
channels. The Hill coefﬁcient of genistein inhibition
was 1.97 
 
6 
 
0.08 (
 
n
 
 
 
5
 
 22) for closed channels and
1.02 
 
6 
 
0.03 (
 
n
 
 
 
5 
 
16) for fully activated channels (Fig. 1
D). This observation suggests that closed channels re-
quire two genistein–PTK complexes for inhibition,
whereas one is sufﬁcient for inhibiting fully activated
channels. However, even in the presence of saturating
cGMP, a fraction of the channels will be in their closed
state because the maximal open probability is 
 
,
 
1.0.
The resulting mixed population of open and closed
channels with different apparent afﬁnities for genistein
could result in an underestimate of the actual numbers
of genistein molecules required to inhibit open chan-
nels (Ruiz et al., 1999)
 
Kinetics of Genistein–PTK Inhibition
 
The observed difference in the apparent afﬁnity of
genistein–PTK for open versus closed channels must
reﬂect state-dependent differences in association and/
or dissociation between the complex and the channel.
To characterize the kinetics of genistein–PTK associa-
tion with closed channels, we recorded a series of resid-
ual cGMP-activated currents at various times after
genistein pretreatment (Fig. 2 A). The genistein associ-
ation time course was reconstructed by plotting resid-
ual current amplitude as a function of pretreatment
duration. The association time course for closed chan-
nels could be ﬁt with a single exponential function with
time constants (
 
t
 
a
 
) of 9.3 s. The time course of gen-
istein inhibition of fully activated channels, determined
by applying genistein after steady-state activation by
saturating cGMP, was ﬁt with a single exponential with
 
t
 
a 
 
5
 
 13.1 s (Fig. 2 B).
Figure 2. Association/dissociation kinetics of genistein–PTK from closed (A and C) and fully activated (B and D) channels. (A) Associa-
tion of genistein–PTK with closed channels. Currents activated by saturating cGMP obtained after preexposure to 100 mM genistein for var-
ious time intervals (1, 2, 5, 10, 15, 20, 25, 30, and 60 s). Open circles represent the amplitude of residual currents that remain uninhibited by
genistein. Dashed curve shows single exponential ﬁt of the data. Inset shows the application protocol. Note that genistein application time
was variable. (B) Association of genistein–PTK with fully activated channels. (C) Dissociation of genistein–PTK from closed channels. After
1 min preexposure to genistein, saturating cGMP was puffed onto the patch every 15 s for 1 s (multiple arrows). Open squares indicate resid-
ual currents resulting from activation of genistein-free channels (D) Dissociation of genistein–PTK from fully activated channels. After 1
min preexposure to genistein, saturating cGMP alone was applied to record the recovery of activated channels from genistein inhibition. 
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The time required for genistein inhibition presum-
ably reﬂects a multistep process, including the time
necessary for genistein to ﬁnd its target, PTK (which is
dependent on genistein concentration) and the time
required for PTK to affect CNG channels (which may
be independent of genistein concentration). We found
that the association time constant, for both closed and
fully activated channels, is independent of genistein
concentration. For closed channels, the 
 
t
 
a 
 
values for 10,
25, and 100 
 
m
 
M genistein were 9.1 
 
6 
 
0.4 (
 
n 
 
5
 
 3), 8.9 
 
6
 
0.6 (
 
n 
 
5
 
 3), and 8.6 
 
6
 
 0.7 s (
 
n 
 
5
 
 6), respectively. For
fully activated channels, the 
 
t
 
a 
 
values for 25, 100, and
250 
 
m
 
M genistein were 12.1 
 
6
 
 0.6 (
 
n 
 
5
 
 5), 12.6 
 
6
 
 0.7
(
 
n 
 
5
 
 12), and 12.6 6 0.9 s (n 5 3), respectively. There-
fore, our observation suggests that this second step, in-
teraction of genistein–PTK with the channel, is the
rate-limiting step of genistein inhibition.
The association rates of genistein are similar for
closed and fully activated channels. To account for the
dramatically different afﬁnity of genistein–PTK for
closed versus open channels, we expect that dissociation
rates should exhibit more substantial differences. To
test how channel opening affects the genistein–PTK
dissociation rate, we used the following procedure.
Genistein was preapplied for 1 min in the absence of
cGMP, ensuring that all closed channels were genistein–
PTK-bound. For analysis of dissociation from closed
channels (Fig. 2 C), genistein was washed away and the
level of remaining genistein inhibition was estimated by
very brieﬂy (1 s) applying saturating cGMP at 15-s inter-
vals during 35–45 min of recording. For analysis of dis-
sociation from fully activated channels, genistein was
immediately replaced with saturating cGMP (Fig. 2 D).
This procedure revealed a dramatic state-dependent dif-
ference in the apparent dissociation rate. For the fully
activated channels, changes in the cGMP-activated cur-
rent could be ﬁt with a single exponential function with
a time constant of 14.4 s. However, for closed channels,
two exponentials were required with time constants of
66 and 808 s. Furthermore, the dissociation rates for
closed channels were probably underestimated, because
the estimated dissociation of genistein was speeded up
by short cGMP application to make the changes in the
inhibition level visible. Despite the fact that these chan-
nels were not continuously maintained in a closed state,
genistein–PTK dissociation was still profoundly slower
Figure 3. Open channels participate in genistein inhibition. (A) Fully activated current inhibited by 100 mM genistein superimposed with
simulations of models in which (1) only closed channels are inhibited, and (2) closed and open channels are inhibited equally. Note that in-
hibition of closed channels alone cannot account for observed current. (B) Dissection of open and open-bound states. Channels were ﬁrst
fully activated with saturating cGMP. Since maximal open probability is 0.9, z90% of the channels were open and 10% were closed.
Genistein was added, cGMP was brieﬂy removed, and then cGMP was reapplied without genistein. Channels that opened rapidly upon reap-
plication of cGMP (Open channels) were genistein–PTK-free (inset), whereas channels that opened sluggishly were genistein–PTK bound.
Since the steady-state current in the presence of genistein was larger than the rapidly activating current upon cGMP reapplication, the differ-
ence between these currents represents open channels that were genistein–PTK-bound (Open-Bound).224 Effect of Genistein on Gating of CNG Channels
than that for fully activated channels. To ensure that
CNG channels were still fully functional in these experi-
ments, long applications of saturating cGMP opened
the channels and accelerated genistein–PTK dissocia-
tion, resulting in full recovery of the cGMP-activated
current with time constant of 2.4 s (Fig. 2 C).
Channels in the Open State Can Be Inhibited by Genistein
Genistein is much more potent at inhibiting closed than
fully activated rod CNG channels. Are open channels af-
fected by genistein, or is genistein inhibition in the pres-
ence of cGMP exclusively due to inhibition during brief
closures that occur even with saturating cGMP? With
saturating cGMP, rod CNG channels have a maximal
open probability of z0.9, indicating that 10% of the
channels are closed at any given moment. Since this
fraction is subject to strong and very slowly reversible
genistein inhibition, the number of inhibited closed
channels would accumulate over time until association
and dissociation of genistein–PTK from the channels
reached equilibrium. Therefore, the apparent inhibi-
tion of open channels might be entirely a result of brief
closures even in the presence of saturating cGMP.
To address whether channels in their open state can
be inhibited by genistein–PTK, we simulated genistein
inhibition (Fig. 3 A, dotted lines) using the dissociation
and association rates determined in Fig. 2. Simulations
were run assuming that only closed channels are subject
to genistein inhibition, or that genistein inhibits open
and closed channels equally. A comparison of the actual
current recording in Fig. 3 A with the predicted cur-
rent (assuming exclusive inhibition of closed channels)
shows that genistein inhibition is faster and more com-
plete than predicted by this model, suggesting that inhi-
bition of open channels also contributes. However, the
actual speed and extent of inhibition are smaller than
the values predicted for equal effects on open and
closed channels. Hence, although open channels appear
to be susceptible to inhibition by genistein–PTK, the ef-
fects appear to be smaller than for closed channels.
To reveal the current ﬂowing through open-bound
channels, fully activated channels were ﬁrst inhibited
with genistein, and then brieﬂy closed by removing
cGMP and genistein for 4 s (Fig. 3 B). Since the dissocia-
tion rate of genistein–PTK from closed channels is very
slow (.1 min; Fig. 2 C), very few of the closed channels
should recover from genistein inhibition during this pe-
riod. When the channels were reopened by subsequent
application of saturating cGMP, there appeared a rapidly
activating residual current, presumably reﬂecting chan-
nels without genistein–PTK bound (open channels). Ap-
plication of various concentrations of cGMP showed that
the residual current exhibits the same dose–response re-
lationship for activation as do normal channels in the ab-
sence of genistein, further supporting the conclusion
that the rapidly activating fraction of current is gener-
ated by channels devoid of genistein–PTK. Close inspec-
tion reveals that the residual current is smaller than the
preceding steady-state current before genistein and
cGMP had been washed away, indicating that a popula-
tion of open-bound channels must have contributed to
the steady-state current. In fact, at least 40% of the
steady-state current ﬂows through open channels that
are genistein–PTK-bound, whereas ,60% comes from
channels devoid of genistein–PTK.
To determine the sensitivity of open-bound channels
to cGMP, we performed the experiment illustrated in
Figure 4. Genistein alters
the apparent afﬁnity of RETa
channels for cGMP. (A)
Dose–response curves for
cGMP activation of CNG
channels in the absence (con-
trol) and in the presence of
100 mM genistein (Open and
Open-Bound channels). Con-
tinuous curves show ﬁts to the
Hill equation. (B) Apparent
afﬁnity (K1/2) for cGMP and
Hill coefﬁcients for control
(n 5 42), genistein-free
(Open,  n 5 22), and gen-
istein-inhibited (Open-Bound,
n 5 22) channels.225 Molokanova and Kramer
Fig. 3 B with different concentrations of cGMP, and
measured the current ﬂowing through open-bound
channels as a fraction of the total control current,
which was measured before genistein application (Fig.
4 A). As compared with control channels, open-bound
channels exhibited a fourfold decrease in the K1/2 for
cGMP, whereas the Hill coefﬁcients were similar (Fig. 4
B). These results suggest that genistein does not affect
the apparent stoichiometry or cooperativity of cGMP
binding and agree with our previous studies (Molo-
kanova et al., 1999a) showing that genistein is not a
competitive inhibitor of cGMP activation.
Effect of Genistein–PTK on Single Channels
To further distinguish between kinetic states, we ana-
lyzed the single channel behavior of rod CNG channels
with and without genistein present. Current carried by
CNG channels can be described with the equation I 5 i
3 N 3 Po, where i is single-channel current, N is a num-
ber of active channels in the patch, and Po is the open
probability. Our ﬁrst goal was to determine which of
these parameters is affected by genistein. Single-chan-
nel currents activated by saturating cGMP in the ab-
sence (Fig. 5 A) and in the presence (Fig. 5 B) of 100
mM genistein appeared to have the same average am-
plitudes, as conﬁrmed by all-point histograms, indicat-
ing that single-channel current was unaffected by
genistein. Likewise, in patches containing 2–3 chan-
nels, genistein did not cause an all-or-none dropout of
individual channel activity, indicating that genistein
does not affect the number of active channels. How-
ever, Fig. 5 shows that genistein dramatically alters the
Po. The control activity pattern exhibited a nearly con-
stant Po of z0.9, but after genistein application, long
closures appeared, such that activity exhibited a
“bursty” pattern with 15–30 s of high Po (0.4–0.9) inter-
spersed with 10–80-s silent periods (Po 5 0). In a total
of eight patches without genistein present (.10 min of
total recording time of single channel activity in satu-
rating cGMP) long closures were never observed,
whereas long closures were consistently observed in
each of the six patches with genistein present (z20
min total recording time). In these six patches, gen-
istein caused a decrease in the average Po of 39 6 6%,
fully accounting for the 41% inhibition of macroscopic
current induced by 100 mM genistein.
While the control gating pattern is relatively simple,
in the presence of genistein, gating appears to ﬂuctuate
from one mode to another, each with distinct gating
characteristics. These modes may correspond to gen-
istein-bound and unbound states, but at steady state, we
have no way to relate channel activity to speciﬁc kinetic
Figure 5. Effects of genistein on single-channel activity. Representative single-channel currents (top), corresponding open probabilities
(middle) sampled in 1-s bins, and all-point amplitude histograms of RETa channel activity activated by saturating cGMP (2 mM). Ampli-
tude histograms were ﬁtted by two Gaussians with variances s2
c and s2
o for closed and open distributions, respectively. All data were ob-
tained at 280 mV. (A) Control single-channel currents. Parameters for Gaussians are as follows: sc 5 0.19 pA, i 51.96 pA, so 5 0.39 pA,
and Po 5 0.94. (B) Single-channel current in the presence of genistein. Parameters for Gaussians are as follows: sc 5 0.23 pA, i 51.97 pA,
so 5 0.38 pA, and Po 5 0.529.226 Effect of Genistein on Gating of CNG Channels
states. Therefore, we examined the behavior of gen-
istein-inhibited rod CNG channels immediately after re-
moval of genistein. Naive channels that had not been
preexposed to genistein activate rapidly with little delay
(,1 s) upon exposure to saturating cGMP, and exhibit
uniform gating with high Po. In contrast, channels pre-
exposed to genistein exhibited a prolonged delay in ac-
tivation upon application of cGMP, followed by bursts
of channel openings, and eventually followed by a re-
turn to the normal (genistein-free) gating pattern (Fig.
6, A and B). The transition from fully inhibited to nor-
mal gating appeared to involve discrete steps. Fig. 6 A
shows an example of the activity pattern seen in three
out of seven experiments, where the Po shifted in a rel-
atively abrupt manner from a very low value (0.02 6
0.01) to z0.9 with only a brief period (,3 s) of inter-
mediate Po values. Fig. 6 B shows an example of chan-
nel behavior seen in the remaining four patches, where
the Po was initially near zero and then shifted in two
distinct steps. The ﬁrst appeared as a burst of openings
and had an average Po of z0.35, followed by an in-
crease to 0.9. Analysis of all four patches that exhibited
an intermediate gating mode indicated that the Po for
this mode was 0.39 6 0.08. The abrupt changes in the
average Po were irreversible, such that channel activity
increased in discrete steps, but never decreased again,
as long as genistein was not reapplied. The irreversible
jumps in open probability are consistent with the
stepwise dissociation of genistein and/or PTK. The
diagrams illustrate the channel conﬁguration that we
propose corresponds to each of the gating modes. As
suggested previously (Molokanova et al., 2000), we pro-
pose that fully inhibited channels are associated with
two PTKs, each bound to a genistein molecule. The
bursty mode, which exhibits an intermediate Po, might
reﬂect activity after one genistein has dissociated. Fi-
nally, the normal gating mode reﬂects activity after
both genistein molecules have dissociated. Further
studies are needed to conﬁrm this proposal, but the ex-
istence of an intermediate gating mode is strong evi-
dence that channels bound to genistein–PTK can
open.
Figure 6. Dissociation of genistein–PTK from single channels. (Top) Two examples of single-channel currents after preexposure to 100
mM genistein. Arrows in A and B show the moment (time 0) when superfusion with solution containing 2 mM cGMP genistein was ap-
plied, washing away the genistein-containing solution. (Middle) Corresponding plots of open probability. In A, note the very low open
probability, followed by an abrupt increase 150 s later, as genistein unbinds. In B, note the two-step increase in open probability, possibly
reﬂecting sequential dissociation of two genistein molecules. Diagrams illustrate tetrameric CNG channels (open symbols), PTK mole-
cules (shaded symbols), and genistein (solid symbols). (Bottom) Amplitude histograms ﬁt with Gaussian distributions. Parameters for
Gaussians are as follows: (A) sc 5 0.21 pA, i 5 1.97 pA, and so 5 0.36 pA; (B) sc 5 0.24 pA, i 5 1.96 pA, and so 5 0.38 pA.227 Molokanova and Kramer
Genistein Changes the Free Energy 
Associated with Channel Opening
To help clarify the mechanism of genistein inhibition,
we used a model for channel activation that involves
the cooperative binding of cyclic nucleotides, fol-
lowed by an allosteric opening transition (Monod et
al., 1965; Stryer, 1987). The opening allosteric con-
stant (L) can be related to open probability according
to the equation L 5 Po/(1 2 Po). Using two values for
Po, reﬂecting one and two genistein molecules bound
(Fig. 6), we ﬁnd that as compared with control, L de-
creased 30–1,000-fold in the presence of genistein
(Lcontrol 5 17 vs. Lgenistein(1) 5 0.61 and Lgenistein(2) 5 0.02).
The free energy associated with channel opening
(DGopening) is related to L by the equation DGopening 5
2RT ln (1/L). According to this model, genistein–
PTK changed DGopening from 21.65 to 0.24 kcal/mol
(one genistein molecule) and 2.21 kcal/mol (two
genistein molecules). Hence, genistein inhibits rod
CNG channels by dramatically raising the DG for the
allosteric opening transition, such that it becomes an
energy-requiring rather than an energy-yielding reac-
tion.
Interaction between Genistein and Ni21
Effects on Rod CNG Channels
To further characterize the changes in the channel be-
havior elicited by genistein, we tested the effect of 10
mM Ni21 on the channels whose gating was impaired by
genistein. Ni21 has been shown to promote rod CNG
channel opening by binding to a speciﬁc histidine on
the COOH terminus of the channel protein and stabi-
lizing the open state (Gordon and Zagotta, 1995a). Fig.
7 shows that the magnitude of Ni21 potentiation at satu-
rating cGMP (2 mM) is much smaller than at low cGMP
(25 mM), presumably because at saturating cGMP, the
open probability is already 0.9, which is very close to
maximal (1.0). At steady state, we ﬁnd that Ni21 com-
pletely eliminates genistein inhibition of channels fully
activated by saturating cGMP (Fig. 7 A), but only re-
duces genistein inhibition at subsaturating cGMP (Fig.
7 B). The effect of Ni21 on genistein inhibition at a vari-
ety of cGMP concentrations is shown in Fig. 7 C. These
Figure 7. Ni21 attenuates genistein inhibition of RETa channels. (A) Effect of genistein on CNG current fully activated by saturating
cGMP, in the absence and presence of 10 mM Ni21. (B) Effect of genistein on CNG current, partially activated by 25 mM cGMP, in the ab-
sence and presence of 10 mM Ni21. (C) Dose–response curves of channel activation in control, genistein, Ni21, and genistein plus Ni21.228 Effect of Genistein on Gating of CNG Channels
effects were observed regardless of the application or-
der of Ni21 and genistein.
We have considered two nonmutually exclusive
explanations that might account for how Ni21 re-
duces genistein inhibition. First, since Ni21 dramati-
cally increases the open probability, perhaps the at-
tenuation of genistein inhibition results solely from
the fact that genistein affects open channels less
strongly than closed channels. However, we have
shown that genistein has a ﬁnite ability to inhibit
open channels. Therefore, the complete absence of
genistein inhibition in the presence of Ni21 sug-
gests that an additional mechanism must be in-
volved.
To determine the extent to which the effect of Ni21
on genistein inhibition results from the increase in
open probability, we calculated the extent of genistein
inhibition and plotted it as a function of open probabil-
ity. Curves relating cGMP concentration to the extent
of genistein inhibition (Fig. 8 A) were transformed into
curves relating open probabilities to the extent of
genistein inhibition (Fig. 8 B) by assuming that with
Ni21 present, saturating cGMP leads to an open proba-
bility very close to 1.0. Hence, data were normalized
with respect to the current elicited by 2 mM cGMP plus
Ni21 (Fig. 8 B, asterisk). If the channel open probability
alone accounts for Ni21 attenuation of genistein inhibi-
tion, then data sets with and without Ni21 should be in-
Figure 8. Analysis of Ni21 attenuation of
genistein inhibition. (A) Genistein inhibition in
the absence and presence of 10 mM Ni21 at various
cGMP concentrations. Genistein inhibition is de-
ﬁned as (control current 2 current with 100 mM
genistein)/control current (n 5 6–9 experiments
for each point). (B) Genistein inhibition as a func-
tion of channel open probability, with and without
Ni21 present. Each data point, taken from the same
experiments shown in A, represents mean 6 SEM
values for percent inhibition of CNG current by
genistein, and mean 6 SEM of open probability.
Figure 9. Ni21 binds to
closed channels and attenu-
ates genistein inhibition. (A)
Ni21 slowly potentiates chan-
nels activated by 25 mM and 2
mM cGMP. (B) Preapplica-
tion of Ni21 on closed chan-
nels potentiates subsequent
activation by cGMP. (C)
Genistein inhibition of closed
channels is reduced by preap-
plication of Ni21.229 Molokanova and Kramer
distinguishable. However, at the same values of open
probability, genistein inhibition is less for channels acti-
vated by cGMP with Ni21 versus channels activated by
cGMP alone. This deviation indicates that an additional
effect must be involved in Ni21 attenuation of gen-
istein–PTK inhibition.
Therefore, we suggest that Ni21 binding alters the
physical association between the channel and the PTK,
making it more difﬁcult for genistein–PTK to affect
channel behavior. We tested this hypothesis using
closed channels. Ni21 associates rather slowly (tens of
seconds) with CNG channels, as demonstrated by the
slow potentiation shown in Fig. 9 A) and by previous
studies (Gordon and Zagotta, 1995a). Pretreatment of
closed channels with Ni21 potentiates the initial cur-
rent immediately upon application by cGMP, suggest-
ing that Ni21 had already bound to the closed channel
(Fig. 9 B). If Ni21 disrupts the association between the
channel and the genistein–PTK complex when the
channel is closed, then upon application of cGMP, one
would expect a larger residual current, reﬂecting chan-
nels devoid of the genistein–PTK complex. We found
that when the channels were pretreated with Ni21
and genistein for 1 min, they exhibited a residual cur-
rent that was 32.1 6 3.4% (n 5 8) of the maximal
current, compared with channels pretreated with
genistein alone, which exhibited a residual current
1.3 6 0.8% (n 5 22) as large as maximal (Fig. 9 C).
The observation that relief of genistein inhibition is
incomplete when Ni21 is applied on closed channels,
but is complete when Ni21 is applied on open chan-
nels suggests that the genistein–PTK–channel com-
plex is more stable when the channel is closed than
when it is open.
Structural Determinants of Genistein Inhibition of Rod
CNG Channels
Which part of the rod CNG channel a-subunit (RETa)
interacts with genistein–PTK and confers inhibition? To
address the question, we took advantage of our previous
ﬁnding that the rat olfactory CNG channel a-subunits
(OLFa), which are highly homologous to the rod chan-
nel, do not exhibit genistein inhibition (Molokanova et
al., 2000). To localize the channel region that confers the
interaction between the RETa channel and genistein–
PTK, we examined chimeric channels (Gordon and Za-
gotta, 1995a,b) containing portions of both channel
sequences (Fig. 10). We used closed channels as an indi-
cator of genistein inhibition because the gating kinetics of
chimeric channels might inﬂuence the level of genistein
inhibition of open channels, whereas closed channels
present no complications associated with channel gating.
We ﬁrst tested the role of speciﬁc histidine residues
that were previously implicated in Ni21 effects on CNG
channels (Gordon and Zagotta, 1995a,b) by using chi-
meras in which amino acids at these positions were ex-
changed with the corresponding amino acids from
OLFa. Substitution of H420 in RETa, which is nec-
essary for Ni21 potentiation, with an asparagine
(CHM25) did not reduce genistein inhibition. Thus,
CHM25, like its parent RETa channel, showed com-
plete inhibition with genistein applied on closed chan-
nels. Likewise, substitution of Q417 with a histidine
(CHM35), which is necessary for Ni21 inhibition of
Figure 10. Structural determinants of genistein
inhibition of RETa channels. (Left) RETa-based
channels (shaded) with substituted regions
containing OLFa sequences (black portions).
(Right) OLFa-based channels (black) with sub-
stituted regions containing RETa sequences
(shaded portions). Pluses and Minuses represent
the presence or absence of genistein inhibition
for each channel.230 Effect of Genistein on Gating of CNG Channels
OLFa channels, also did not reduce genistein inhibi-
tion. The converse chimeras (CHM34 and CHM 30) in
which substitutions were made into the OLFa back-
ground also had no effect: neither substitution intro-
duced genistein inhibition.
Exchange of the cyclic nucleotide–binding domains
between RETa and OLFa channels did not alter
genistein inhibition. Thus, RETa channels with the
OLFa cyclic nucleotide–binding domain (CHM17) ex-
hibited complete inhibition by genistein, whereas the
OLFa channel with a RETa cyclic nucleotide–binding
domain (CHM18) exhibited no inhibition. Switching
the NH2-terminal domains through part of the ﬁrst
membrane-spanning segment (CHM 15 and CHM16)
also had no effect; either chimera behaved like their re-
spective RETa or OLFa parent channel. Substitution
from mid-S1 through S4, including all of S2 and S4 also
had no effect. Thus, CHM12, which consisted of RETa
except for this region was fully inhibited by genistein,
whereas CHM 14, which consisted of OLFa except for
this region was not inhibited.
We were able to alter genistein inhibition of RETa
channels by substituting “a pore module” derived from
the OLFa channel, including S5, the pore-forming P
region, S6, and the initial part of the C-linker ﬂanking
S6 (CHM11). In the open state, this chimera was com-
pletely insensitive up to 500 mM genistein; in the closed
state, maximal inhibition caused by 500 mM genistein
was only z15 vs. 98% in wild-type channel, suggesting
that this region contains most, but not all, of the sites
necessary for genistein–PTK interaction. We tested
three parts of the S5-P-S6 region separately. Exchange
of S5 domains between RETa and OLFa channels
(CHM20 and CHM22) and introduction of the OLFa
pore into RETa channel (CHM 19) did not alter
genistein inhibition. However, introduction of a region
including part of the pore, S6, and part of the C-linker
from the RETa into the OLFa channel (CHM23) had a
dramatic effect. Indeed, the resulting channel was sus-
ceptible to genistein inhibition to the same extent as
RETa channels (99% inhibition of closed channels).
Thus, introduction of the RETa S6 and ﬂanking re-
gions was the only change capable of conferring
genistein inhibition onto the OLFa channel. These re-
sults suggest that the region in or around transmem-
brane domain S6 (namely, amino acids 343–421) is cru-
cial for genistein inhibition, and may be the genistein–
PTK binding site on the RETa channel.
DISCUSSION
Noncatalytic Inhibition of CNG Channels by PTK
PTKs can inﬂuence RETa channels in two ways: (1) by
catalyzing phosphorylation, and (2) by noncatalytically
inhibiting the channels in the presence of genistein
(Molokanova et al., 1997, 1999a,b). Noncatalytic gen-
istein inhibition can be studied in isolation by recording
channel activity from excised patches in the absence of
ATP. Several key observations lead to the conclusion
that noncatalytic inhibition by genistein is mediated by
PTKs. First, PTK inhibitors that have no direct effect on
the channel attenuate genistein inhibition. Second, the
association and dissociation rates of genistein inhibition
are orders of magnitude slower than predicted from the
diffusion coefﬁcient of genistein, which is inconsistent
with a direct interaction between genistein and the
channels. Third, for genistein concentrations of 1 mM
and above, the on-rate of inhibition is independent of
genistein concentration, which is also inconsistent with
a direct interaction between genistein and the channels.
Finally, the activity-dependent pattern observed for cata-
lytic modulation by the PTK (tyrosine phosphorylation
requires closed channels) matches the activity-depen-
dence of noncatalytic genistein inhibition. In parallel
with tyrosine phosphorylation, genistein is both more
potent and more efﬁcacious in inhibiting closed than
open channels.
All of these observations lead to the proposal that
genistein inhibits RETa channels by ﬁrst binding to
a PTK, which then impairs channel gating. The ob-
servation that the on-rate of genistein inhibition is
independent of genistein concentration is consistent
with the second step in this process being rate-limit-
ing. It is unclear whether the PTK is stably associated
with the channel, or whether the PTK can dissociate
and associate with the channel. If the PTK is stably
bound to the channel, then the slow kinetics of inhi-
bition must reﬂect slow conformational changes in-
duced by genistein. If the PTK can dissociate, the
slow kinetics might reﬂect the diffusion of genistein–
PTK and binding and unbinding of the complex and
the channel.
Genistein is much more effective in inhibiting closed
than open channels. While genistein inhibition of closed
channels is dramatic and complete, we have shown that
open channels can also bind genistein–PTK, causing a
less pronounced degree of inhibition. The act of open-
ing, which has been suggested to involve the S6 trans-
membrane domain, may decrease the stability of binding
of channels to genistein–PTK. The association rate of
genistein–PTK to either closed and open channels ap-
pear to be very similar, whereas dissociation of genistein–
PTK occurs much more rapidly from open than from
closed channels. Hence, opening channels with cGMP
should cause a great acceleration of dissociation, ensur-
ing more rapid recovery from genistein inhibition.
Noncatalytic genistein inhibition occurs not only in
RETa channels exogenously expressed in oocytes, but
also in native CNG channels from rod outer segments
(Molokanova et al., 2000). This ﬁnding suggests that
PTK(s) may be normal components of the phototrans-
duction machinery that have important, but incom-231 Molokanova and Kramer
pletely understood, roles in phototransduction. We have
described the PTK as an inhibitory regulator of CNG
channel function, such that genistein inhibits by allow-
ing a negative association between the channel and the
PTK. However, our results do not exclude the converse
possibility that genistein disrupts a positive association
between channel and the PTK. This second possibility
would imply that the PTK has a permissive role in pro-
moting channel gating, which is suppressed by genistein.
Structural Basis of Genistein Inhibition
The site in the RETa channel that confers genistein in-
hibition on OLFa channels is a region containing all of
the S6 transmembrane domain and neighboring regions
of the pore and part of the cytoplasmic C-linker (CHM
23). Genistein inhibition of RETa channels can be
greatly reduced, but not completely eliminated, by sub-
stitution of a similar and overlapping region spanning
from S4 to S6 from OLFa (CHM 11). No other parts of
the channel appear crucial for allowing inhibition of
RETa or conferring inhibition to OLFa channels. The
simplest explanation for these mapping results is that
the region in and around S6 is important, but other
parts of the RETa channel protein also contribute to the
binding site of genistein–PTK. Notably, the tyrosine
phosphorylation site (Y498) responsible for catalytic
modulation (i.e., phosphorylation) by PTKs (Moloka-
nova et al., 1999b) is not required for genistein inhibi-
tion. To transfer a phosphate, PTKs must interact with
the RETa channel at Y498. However, the binding site for
the PTK must involve a much larger protein interface,
apparently including a more distant region that may be
primarily intramembranous (S6 and ﬂanking regions).
Both genistein inhibition and the ability to modulate
rod CNG channels by tyrosine phosphorylation are re-
markably stable in membrane patches excised from Xe-
nopus oocytes, persisting unabated for .30 min, even
with continuous perfusion. Loosely associated mem-
brane constituents, such as G-protein subunits, cyto-
skeletal components, and soluble kinases and phos-
phatases (Levitan, 1999) are often stripped from
membranes after cell dialysis or patch excision, resulting
in wash-out of channel modulation or, in some cases,
loss of channel activity itself. The observation that the
catalytic and noncatalytic effects of the PTK are so sta-
ble is consistent with an integral membrane protein,
rather than a loosely associated protein, being involved.
The possible involvement of the S6 transmembrane do-
main as a binding interface for the PTK is consistent
with this idea. Cysteine accessibility studies on voltage-
gated K1 channels, which are closely homologous to
CNG channels, show that the S6 domain plays a central
role controlling intracellular access to the pore, suggest-
ing that S6 constitutes part of the channel’s gate (Liu et
al., 1997). The important role of S6 in gating may pro-
vide a direct mechanism for how genistein–PTK inhibits
channel opening. In addition, the C-linker also has
been implicated in regulating CNG channel gating
(Zong et al., 1998; Paoletti et al., 1999), providing an ad-
ditional possible basis for genistein–PTK inhibition.
Interaction of Ni21 Potentiation and Genistein Inhibition
Ni21 increases current through RETa channels and in-
creases the apparent afﬁnity for cyclic nucleotides
(Gordon and Zagotta, 1995a). Ni21 potentiation in-
volves the coordination of histidines (H420) in adja-
cent subunits of the channel (Gordon and Zagotta,
1995b). We have found that Ni21 dramatically reduces
genistein inhibition. Since Ni21 increases open proba-
bility and genistein has a diminished effect on open
channels, one would expect some relief of genistein in-
hibition in the presence of Ni21. However, Ni21 has an
additional liberating effect on genistein inhibition,
above and beyond that predicted by changes in open
probability alone (Fig. 8 B). We propose that the con-
formational change triggered by Ni21 affects the
channel’s ability to interact with genistein–PTK. The
genistein–PTK binding region includes the speciﬁc
binding site for Ni21, but we have found that replacing
the histidine with a glutamine (H420Q), fails to pre-
vent genistein inhibition. Hence, even though Ni21 and
genistein–PTK have overlapping binding regions, mu-
tation of the more focused binding site for Ni21 has an
insigniﬁcant effect on genistein inhibition. Since Ni21
and genistein–PTK interact with the same part of the
CNG channel, it is possible they affect the same under-
lying process (e.g., the same or similar conformational
changes), albeit in opposite ways. PTKs involved in
genistein inhibition are natural constituents of both
oocytes and rods (Molokanova et al., 2000). Hence, it is
possible that the Ni21 potentiation observed in both of
these systems is actually an indirect effect, involving re-
lief of PTK inhibition. According to this idea, even
though Ni21 binds directly to the channel, its ability to
potentiate gating results from an allosteric decrease in
the binding of the channel to the PTK. In effect, Ni21
potentiation may be mediated by PTK disinhibition.
How Does the Association between Channel and PTK Affect 
Channel Behavior?
Allosteric models involving concerted conformational
changes between closed and open states, based on the
classic model devised for hemoglobin (Monod et al.,
1965), have been used to describe the activation of CNG
channels (Stryer, 1987; Goulding et al., 1993; Liu et al.,
1998; Ruiz and Karpen, 1999). According to these mod-
els, cyclic nucleotides preferentially bind and stabilize
channels in their open states rather than binding to
closed states and triggering channel opening. CNG chan-
nels open spontaneously without a ligand (Tibbs et al.,232 Effect of Genistein on Gating of CNG Channels
1997), indicating that conformation changes resulting in
channel opening can occur separately from ligand bind-
ing and can be analyzed independently.
Application of genistein on fully activated channels
results in a fourfold decrease in cGMP sensitivity. This
could result from a decrease in the binding afﬁnity for
cyclic nucleotides or from a change in the energetics of
channel opening. If genistein–PTK lowered the bind-
ing afﬁnity for cGMP, one would expect that, in the
presence of genistein, the gating pattern of single
channels at high concentrations of cGMP would simply
resemble the gating at low concentrations of cGMP.
However, genistein–PTK induces a novel gating pat-
tern, consisting of bursts of high open probability inter-
spersed with silent periods, unlike the uniformly low
open probability normally seen at low concentrations
of cGMP. Hence, an effect on cGMP binding afﬁnity
alone cannot account for genistein inhibition. There-
fore, at least some of genistein inhibition must result
from a change in the process of channel gating.
To quantify the effect of genistein on channel gating,
we measured the open probability of single genistein–
PTK-bound channels by taking advantage of the slow
dissociation rate of the complex from closed channels.
At steady state, it is difﬁcult to ascertain the number of
genistein–PTK complexes bound to a channel at any
given moment. However, by capturing channel gating as
genistein–PTK is dissociating, we observed three se-
quential modes of channel gating, each with progres-
sively higher open probability, as the channel returns
to normal activity. At ﬁrst, the maximal number of
genistein–PTK complexes are still bound to the chan-
nels. The value of the Hill coefﬁcient for genistein inhi-
bition is 2, and our previous studies (Molokanova et al.,
2000) suggest that closed RETa channels can bind up
to two genistein–PTKs. Therefore, we suggest that the
initial gating mode, exhibiting the lowest maximal open
probability, corresponds to channels with two genistein–
PTK complexes. Next, the channels exhibit an interme-
diate gating mode, corresponding to one genistein–
PTK complex bound. Finally, the channel exhibits its
normal high open probability, corresponding to com-
plete dissociation of genistein–PTK from the channel.
The energetics of channel gating progressively becomes
more favorable as the channel sequentially sheds the
two genistein–PTK complexes. With two genistein–PTK
complexes bound, the DGopening is positive (12.13 kcal/
mol) and is very close to the value for normal channels
with cAMP bound (12.26 kcal/mol), a very poor partial
agonist. Hence, we conclude that by binding to regions
of the channel important for gating, genistein–PTK im-
poses conformational constraints on the channel pro-
tein, hindering the ability of the channel to open.
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